FAQs

Multiple myeloma is a type of blood cancer that occurs when cancerous cells called myeloma cells build up in the bone marrow. Myeloma cells can crowd out healthy blood cells and cause harmful blood problems, as well as destroy bone tissue, causing pain, fractures, and elevated calcium levels.

People with multiple myeloma often have tumors called plasmacytomas in different bones or areas of the body.2 These cancerous cells can also reduce the number of healthy blood cells in the body, increasing the risk of infections. Multiple myeloma is more common in older adults, men, Black people, and first-degree relatives of people with the disease.2,3 There are many treatment options available for multiple myeloma, and scientists continue to learn more about the disease.3

Multiple myeloma typically starts with a gene mutation that turns normal plasma cells into harmful myeloma cells that can damage your body.4 These abnormal plasma cells can make new myeloma cells and antibodies that can harm your bone, kidneys, and other organs. Fortunately, the types of mutations that cause multiple myeloma are not typically passed down in families. Even so, you may have a higher risk for myeloma if another family member also had myeloma.4

Multiple myeloma affects the bones and bone marrow and often results in bone pain, fatigue, and frequent infections.5 Malignant cells in multiple myeloma can facilitate damage to bones, which may lead to fractures, bone pain, and fatigue.

Myeloma can also cause anemia, which can contribute to fatigue as well. Your tendency to bruise or bleed might also increase, as platelet counts might be affected.5 Monitoring of platelet counts is an important consideration.5 Kidney damage can also occur, so monitoring your kidney function is also an important part of treatment.5

The two basic types of multiple myeloma are classified as active and smoldering. Unlike smoldering multiple myeloma, active myeloma causes symptoms, affects organs, and it often occurs in patients who previously had smoldering multiple myeloma.7

Smoldering myeloma usually does not require immediate treatment, but instead regular testing that can help identify important clues that the condition is progressing.7 For example, your oncologist might check for a high level of M-protein, kidney problems, bone lesions, too much calcium, too few red blood cells in the bloodstream, and other signs of myeloma. While myeloma that is causing symptoms should be treated, results from certain lab tests can also show that it is time to start treatment.3,7

Multiple myeloma is the second most common blood cancer in the United States, and it is the most common blood cancer for Black patients.9,10 For the year 2024, the National Cancer Institute projected the diagnosis of 35,780 new cases of multiple myeloma in the United States.11

The diagnosis of multiple myeloma requires the presence of a plasmacytoma through a bone marrow biopsy or a presence of ≥10% clonal bone marrow plasma cells. In addition, there must be the presence of one more of the following:12

  • CRAB findings (high levels of calcium in the blood, renal (kidney) failure, anemia, or lytic lesions (damaged bone appearing as holes on X-ray)
  • Increase in the relative amount of a type of light chain found in the blood
  • A level of plasma cells in the bone marrow ≥60%
  • Multiple focal lesions on magnetic resonance imaging

References

  1. Cleveland Clinic. Multiple Myeloma. May 4, 2022. https://my.clevelandclinic.org/health/diseases/6178-multiple-myeloma
  2. National Cancer Institute. Plasma Cell Neoplasms (Including Multiple Myeloma) Treatment (PDQ®)–Patient Version. November 17, 2023. https://www.cancer.gov/types/myeloma/patient/myeloma-treatment-pdq
  3. National Comprehensive Cancer Network®. NCCN Guidelines for Patients. Multiple Myeloma, 2023. https://www.nccn.org/patients/guidelines/content/PDF/myeloma-patient.pdf
  4. City of Hope. Multiple myeloma causes and risk factors. 2024. https://www.cancercenter.com/cancer-types/multiple-myeloma/risk-factors
  5. Moffitt Cancer Center. Multiple Myeloma Symptoms. 2024. https://www.moffitt.org/cancers/multiple-myeloma-plasma-cell-tumor/signs-symptoms/
  6. Christiansen S. What Is Multiple Myeloma? Verywell Health. June 25, 2022. https://www.verywellhealth.com/multiple-myeloma-overview-4586928
  7. International Myeloma Foundation. What are MGUS, Smoldering Multiple Myeloma, and Active Myeloma? 2024. https://www.myeloma.org/what-are-mgus-smm-mm
  8. Adapted from: Memorial Sloan Kettering Cancer Center. Multiple Myeloma. https://www.mskcc.org/cancer-care/types/multiple-myeloma
  9. International Myeloma Foundation. What is multiple myeloma? FAQs. https://www.myeloma.org/myeloma-cancer-questions
  10. Mikhael J, Bhutani M, Cole CE. Multiple myeloma for the primary care provider: A practical review to promote earlier diagnosis among diverse populations. Am J Med. 2023;136:33-41.
  11. Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74:12-49.
  12. Rajkumar SV. Multiple myeloma: 2022 update on diagnosis, risk-stratification and management. Am J Hematol. 2022;97:1086-1107.
  13. Cancer Support Community. Multiple Myeloma. https://www.cancersupportcommunity.org/multiple-myeloma

ALL URLs accessed August 30, 2024

Pin It on Pinterest

Scroll to Top

For optimized Clinical Trial Tracker use, please utilize Chrome or Firefox browsers